Serum interleukin-9 levels are associated with clinical severity in children with atopic dermatitis

Pediatric Dermatology

Volumn 30, Issue 2, 2013, Pages 222-225

  Ciprandi, Giorgio ^a   De Amici, Mara ^b   Giunta, Vania ^b   Marseglia, Alessia ^c   Marseglia, Gianluigi ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b Hospital Pediatric Clinic   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 9;

ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRESCHOOL CHILD; PRIORITY JOURNAL; SCORING ATOPIC DERMATITIS INDEX; SYMPTOM ASSESSMENT;

CHILD; DERMATITIS, ATOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-9; MALE; SEVERITY OF ILLNESS INDEX;

EID: 84874941248     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2012.01766.x     Document Type: Article

References (16)

1. Williams H, Robertson C, Stewart A, et al., Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103 (1 Pt 1): 125-138.
2. Akdis CA, Akdis M,. Mechanisms and treatment of allergic disease in the big picture of T regulatory cells. J Allergy Clin Immunol 2009; 123: 735-746.
3. Veldhoen M, Uyttenhove C, van Snick J, et al., Transforming growth factor-beta "reprograms" the differentiation of T helper 2 cells and promotes an IL-9-producing subset. Nat Immunol 2008; 9: 1341-1346.
4. Dardalhon V, Awasthi A, Kwon H, et al., IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 2008; 9: 1347-1355.
5. Nouri-Aria KT, Pilette C, Jacobson MR, et al., IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy. J Allergy Clin Immunol 2005; 116: 73-79.
6. Ciprandi G,. Serum IL-9 in allergic rhinitis. Ann Allergy Asthma Immunol 2010; 104: 180-181.
7. Namkung JH, Lee JE, Kim E, et al., An association between IL-9 and IL-9 receptor gene polymorphisms and atopic dermatitis in a Korean population. J Dermatol Sci 2011; 62: 16-21.
8. Rajka G, Langeland T,. Grading of severity of atopic dermatitis. Acta Drm Venerol 1989; 144: 13-14.
9. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
10. Diepgen TL, Early Treatment of the Atopic Child Study Group. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol 2002; 13: 278-286.
11. Soroosh P, Doherty TA,. Th9 and allergic disease. Immunology 2009; 127: 450-458.
12. Steenwinckel V, Louahed J, Lemaire MM, et al., IL-9 promotes IL-13-dependent Paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa. J Immunol 2009; 182: 4737-4743.
13. Singhera GK, MacRedmond R, Dorscheid DR,. IL-9 promotes IL-13-dependent Paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa. Exp Lung Res 2008; 34: 579-598.
14. Xiang J, Rir-Sim-Ah J, Tesfaigzi Y,. IL-9 promotes IL-13-dependent Paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa. Am J Respir Cell Mol Biol 2008; 38: 310-317.
15. Steenwickel V, Louahed J, Orabona C, et al., IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells. J Immunol 2007; 178: 3244-3251.
16. Yanaba K, Yoshizaki A, Asano Y, et al., Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis. J Rheumatol 2011; 38: 2193-2197.